Siemens Healthineers closes fast track testing arm
The German-multinational company has announced plans to close its fast-track diagnostics arm, putting 90 jobs at risk and pivoting away from a Covid-19 era business.
21 March 2024
21 March 2024
The German-multinational company has announced plans to close its fast-track diagnostics arm, putting 90 jobs at risk and pivoting away from a Covid-19 era business.
The blood-based test will measure levels of phosphorylated tau 217 (pTau217), a known Alzheimer’s biomarker.
The dispute over salary rolls on as the UK’s British Medical Association announces a further six months of strike action among junior doctors demanding better pay.
The OSPREY trial for sleep apnoea treatment concluded early with positive outcomes.
The trial will enhance genetic testing and treatment personalisation for ovarian cancer in Canada.
The plan to sell the MDC division is part of a strategic divestment programme of Johnson Matthey initiated in May 2022.
The company’s AI-based system improves the detection of pre-cancerous lesions of varying sizes, shapes, and colours.
Coming ahead of a planned pre-market approval to the FDA, the topline results found that Cerus’ blood system saw only a 2.5% rate of adverse events.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.